Watford add to Luton’s relegation fears as Kayembe seals painful derby defeat
Nigeria sues crypto giant Binance for $81.5bn in economic losses and back tax
‘You dream about such things’: Brit who discovered missing pharaoh’s tomb may have unearthed another
Xi Jinping tells Alibaba’s Jack Ma and Chinese tech chiefs to ‘show their talent’
Willingness to ease off ‘debt brake’ may decide the German election
Nice approves rimegepant for preventing migraines in cases where at least three previous treatments have failed
Thousands of people in England who get migraines could benefit from a drug that has been approved on the NHS.
The National Institute for Health and Care Excellence (Nice), the drugs regulator, said it was recommending rimegepant for preventing migraines in the approximately 145,000 adults where at least three previous preventive treatments had failed.
More Stories
Microsoft unveils chip it says could bring quantum computing within years
I became absorbed in strangers’ fertility journeys online
Virologist Wendy Barclay: ‘Wild avian viruses are mixing up their genetics all the time. It’s like viral sex on steroids’